Detection of NRG1 Gene Fusions in Solid TumorsNRG1 Fusions in Solid Tumors S Jonna, RA Feldman, J Swensen, Z Gatalica, WM Korn, H Borghaei, ... Clinical Cancer Research 25 (16), 4966-4972, 2019 | 183 | 2019 |
Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1 U Joneja, S Vranic, J Swensen, R Feldman, W Chen, J Kimbrough, ... Journal of clinical pathology 70 (3), 255-259, 2017 | 119 | 2017 |
Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma JY Hou, C Baptiste, RB Hombalegowda, AI Tergas, R Feldman, NL Jones, ... Cancer 123 (8), 1333-1344, 2017 | 118 | 2017 |
Molecular profiling of head and neck squamous cell carcinoma R Feldman, Z Gatalica, J Knezetic, S Reddy, CA Nathan, N Javadi, ... Head & neck 38 (S1), E1625-E1638, 2016 | 113 | 2016 |
Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma PA Philip, I Azar, J Xiu, MJ Hall, AE Hendifar, E Lou, JJ Hwang, J Gong, ... Clinical Cancer Research, OF1-OF11, 2022 | 80 | 2022 |
Apocrine carcinoma of the breast: A brief update on the molecular features and targetable biomarkers S Vranic, R Feldman, Z Gatalica Bosnian journal of basic medical sciences 17 (1), 9, 2017 | 58 | 2017 |
Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling SM Gargano, W Senarathne, R Feldman, E Florento, P Stafford, ... Cancer Medicine 8 (17), 7322-7329, 2019 | 53 | 2019 |
COX-2 overexpression as a biomarker of early cervical carcinogenesis: a pilot study JS Saldivar, D Lopez, RA Feldman, R Tharappel-Jacob, A de la Rosa, ... Gynecologic oncology 107 (1), S155-S162, 2007 | 52 | 2007 |
Molecular profiling for cancer G Basu, D Arguello, R Feldman, XIU Xinan, Z Gatalica US Patent App. 14/648,988, 2015 | 46 | 2015 |
Comparative molecular profiling of HPV‐induced squamous cell carcinomas RF Koncar, R Feldman, EM Bahassi, N Hashemi Sadraei Cancer medicine 6 (7), 1673-1685, 2017 | 43 | 2017 |
derived Pseudomyxoma Peritonei (PMP) EM Gleeson, R Feldman, BL Mapow, LT Mackovick, KM Ward, ... American journal of clinical oncology 41 (8), 777-783, 2018 | 42 | 2018 |
Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung B McCullar, M Pandey, G Yaghmour, F Hare, K Patel, M Stein, R Feldman, ... Breast cancer research and treatment 158 (1), 195-202, 2016 | 39 | 2016 |
Clinical, pathological, and molecular profiling of radioactive iodine refractory differentiated thyroid cancer L Shobab, C Gomes-Lima, A Zeymo, R Feldman, J Jonklaas, L Wartofsky, ... Thyroid 29 (9), 1262-1268, 2019 | 36 | 2019 |
Identification of molecular targets in vulvar cancers ML Palisoul, MM Mullen, R Feldman, PH Thaker Gynecologic oncology 146 (2), 305-313, 2017 | 35 | 2017 |
Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas J Topcagic, R Feldman, A Ghazalpour, J Swensen, Z Gatalica, S Vranic PLoS One 13 (1), e0191244, 2018 | 34 | 2018 |
Hsf1 is required for the nuclear translocation of p53 tumor suppressor Q Li, RA Feldman, VM Radhakrishnan, S Carey, JD Martinez Neoplasia 10 (10), 1138-1145, 2008 | 33 | 2008 |
Growth suppression by ursodeoxycholic acid involves caveolin-1 enhanced degradation of EGFR R Feldman, JD Martinez Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1793 (8), 1387-1394, 2009 | 32 | 2009 |
Resistance to ursodeoxycholic acid-induced growth arrest can also result in resistance to deoxycholic acid-induced apoptosis and increased tumorgenicity AA Powell, S Akare, W Qi, P Herzer, S Jean-Louis, RA Feldman, ... BMC cancer 6 (1), 1-9, 2006 | 32 | 2006 |
Molecular profiling of immune modulators Z Gatalica, G Basu, R Feldman, S Millis US Patent App. 15/115,617, 2017 | 30 | 2017 |
Update on EGFR Mutational Testing and the Potential of Noninvasive Liquid Biopsy in Non–Small-cell Lung Cancer E Kim, R Feldman, II Wistuba Clinical Lung Cancer 19 (2), 105-114, 2018 | 22 | 2018 |